Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
3050.0000 -2.10 (-0.07%)
NSE Dec 02, 2025 14:04 PM
Volume: 154.1K
 

3050.00
-0.07%
Prabhudas Lilladhar
28-30% of revenue compared to last year in Q1FY21E and gradual recovery from Q2FY21E. As per the management, 60-65% of DLPL's total operating cost is fixed in nature and the new additional expense (cost of safety for...
Number of FII/FPI investors increased from 358 to 391 in Sep 2025 qtr.
More from Dr. Lal Pathlabs Ltd.
Recommended